Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M et al (2020) Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 395:709–733

Article  Google Scholar 

Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047

Article  CAS  PubMed  Google Scholar 

Hsu C, Vittinghoff E, Lin F, Shlipak MG (2004) The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 141:95–101

Article  PubMed  Google Scholar 

Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER, Saran R et al (2008) Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med 168:2268–2275

Article  PubMed  PubMed Central  Google Scholar 

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B et al (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382:260–272

Article  PubMed  Google Scholar 

Dunkler D, Kohl M, Heinze G, Teo KK, Rosengren A, Pogue J et al (2015) Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus. Kidney Int 87:784–791

Article  CAS  PubMed  Google Scholar 

Stanzick KJ, Li Y, Schlosser P, Gorski M, Wuttke M, Thomas LF et al (2021) Discovery and prioritization of variants and genes for kidney function in >1.2 million individuals. Nat Commun 12:4350

Article  CAS  PubMed  PubMed Central  Google Scholar 

Collins AJ, Foley RN, Gilbertson DT, Chen S-C (2015) United states renal data system public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl 5:2–7

Article  Google Scholar 

Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE (2011) Biomarkers in chronic kidney disease: a review. Kidney Int 80:806–821

Article  CAS  PubMed  Google Scholar 

Wang Y-N, Ma S-X, Chen Y-Y, Chen L, Liu B-L, Liu Q-Q et al (2019) Chronic kidney disease: biomarker diagnosis to therapeutic targets. Clin Chim Acta 499:54–63

Article  CAS  PubMed  Google Scholar 

Chen H, Chen L, Liu D, Chen D-Q, Vaziri ND, Yu X-Y et al (2017) Combined clinical phenotype and lipidomic analysis reveals the impact of chronic kidney disease on lipid metabolism. J Proteome Res 16:1566–1578

Article  CAS  PubMed  Google Scholar 

Duranton F, Lundin U, Gayrard N, Mischak H, Aparicio M, Mourad G et al (2014) Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function. CJASN 9:37–45

Article  CAS  PubMed  Google Scholar 

Goek O-N, Döring A, Gieger C, Heier M, Koenig W, Prehn C et al (2012) Serum metabolite concentrations and decreased GFR in the general population. Am J Kidney Dis 60:197–206

Article  CAS  PubMed  Google Scholar 

Chen D-Q, Cao G, Chen H, Liu D, Su W, Yu X-Y et al (2017) Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease. Redox Biol 12:505–521

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo S, Coresh J, Tin A, Rebholz CM, Appel LJ, Chen J et al (2019) Serum metabolomic alterations associated with proteinuria in CKD. CJASN 14:342–353

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hallan S, Afkarian M, Zelnick LR, Kestenbaum B, Sharma S, Saito R et al (2017) Metabolomics and gene expression analysis reveal down-regulation of the citric acid (TCA) cycle in non-diabetic CKD patients. EBioMedicine 26:68–77

Article  PubMed  PubMed Central  Google Scholar 

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612

Article  PubMed  PubMed Central  Google Scholar 

Soininen P, Kangas AJ, Würtz P, Suna T, Ala-Korpela M (2015) Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet 8:192–206

Article  CAS  PubMed  Google Scholar 

Ellul S, Wake M, Clifford SA, Lange K, Würtz P, Juonala M et al (2019) Metabolomics: population epidemiology and concordance in Australian children aged 11–12 years and their parents. BMJ Open 9:106–117

Article  PubMed  PubMed Central  Google Scholar 

Qian C, Nusinovici S, Thakur S, Soh ZD, Majithia S, Chee ML et al (2022) Machine learning identifying peripheral circulating metabolites associated with intraocular pressure alterations. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2021-320584

Article  PubMed  Google Scholar 

Lee J, Choi J-Y, Kwon Y-K, Lee D, Jung H-Y, Ryu H-M et al (2016) Changes in serum metabolites with the stage of chronic kidney disease: comparison of diabetes and non-diabetes. Clin Chim Acta 459:123–131

Article  CAS  PubMed  Google Scholar 

Kopple JD (2007) Phenylalanine and tyrosine metabolism in chronic kidney failure. J Nutr 137:1586S-1590S

Article  CAS  PubMed  Google Scholar 

Jia L, Chen J, Yin P, Lu X, Xu G (2008) Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry. Metabolomics 4:183–189

Article  CAS  Google Scholar 

Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M et al (2010) Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res 33:944–952

Article  PubMed  Google Scholar 

Qi S, Ouyang X, Wang L, Peng W, Wen J, Dai Y (2012) A pilot metabolic profiling study in serum of patients with chronic kidney disease Based on 1 H-NMR-spectroscopy. Clin Transl Sci 5:379–385

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roointan A, Gheisari Y, Hudkins KL, Gholaminejad A (2021) Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: meta-analysis of profiling metabolomics studies. Nutr Metab Cardiovasc Dis 31:2253–2272

Article  CAS  PubMed  Google Scholar 

Zhang Z-H, Li M-H, Liu D, Chen H, Chen D-Q, Tan N-H et al (2018) Rhubarb protect against tubulointerstitial fibrosis by inhibiting TGF-β/Smad pathway and improving abnormal metabolome in chronic kidney disease. Front Pharmacol 9:1029

Article  PubMed  PubMed Central  Google Scholar 

Bermúdez-López M, Arroyo D, Betriu À, Masana L, Fernández E, Valdivielso JM (2017) New perspectives on CKD-induced dyslipidemia. Expert Opin Ther Targets 21:967–976

Article  PubMed  Google Scholar 

Yu Z, Kastenmüller G, He Y, Belcredi P, Möller G, Prehn C et al (2011) Differences between human plasma and serum metabolite profiles. PLoS ONE 6:e21230

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar